N/A N=40 Treatment

PRESERVE-Zenith® Iliac Branch System Clinical Study

Aorto-iliac Aneurysms · Iliac Aneurysms

Bottom Line

View on ClinicalTrials.gov: NCT01208415 ↗

Enrolled (actual)

Serious AEs

17.5%

Results posted

Aug 2017

Primary outcome: Primary: Patients That Are Free From Patency-related Intervention — 33 participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Endovascular repair for aortoiliac or iliac aneurysms. (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Cook Group Incorporated
Primary completion: Oct 2012

Outcome Measures

Outcome	Result	p-value
PRIMARY Patients That Are Free From Patency-related Intervention	33	—

Summary

The PRESERVE-Zenith® Iliac Branch System Clinical Study is a clinical trial to study the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the Zenith® Connection Endovascular Stent/ConnectSX™ covered stent in the treatment of aorto-iliac and iliac aneurysms.

Eligibility Criteria

Inclusion Criteria

An aortoiliac or iliac aneurysm of appropriate size
Unsuitable distal sealing site for a traditional Zenith® iliac leg graft within the common iliac artery

Exclusion Criteria

Less than 18 years of age
Inability or refusal to give informed consent
Disease considerations that would compromise patient safety or study outcomes
Unsuitable arterial anatomy

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01208415). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.